Search

The June Halper Memorial Lecture: The Journey is the Destination: 40 Years of CMSC, 40 Years of MS Neuropsychiatry

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …

Bugs and Drugs: Practical Management Considerations Around Infections and MS Disease Modifying Therapies

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …

Turning the Tide on MS: Prodrome and Prevention Organized by the VA MSCoE

2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This clinical course will present the current understanding of the MS prodrome. The MS prodrome will be contrasted with other neurological conditions. The diagnosis of the radiologically isolated syndrome and clinical management will be highlighted. Using data from population-based studies, risk factors for MS …

Era of Too Many Choices; Starting and Switching

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE There has been an explosion of new MS disease modifying therapies over the last decade. These therapies offer people with MS many treatment options including different routes of administration and mechanisms of action. With so many treatment options, selecting the right therapy for …

Great Debate in MS Nursing: Are Digital Tools Enhancing or Eroding Patient Relationships?

2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE Digital health tools are rapidly reshaping how multiple sclerosis (MS) care is delivered. Telehealth visits, remote monitoring platforms, electronic patient-reported outcomes, and mobile apps now play a central role in how MS nurses, advanced practice providers, and PAs connect with patients. While these tools …

Integrating Wearables into MS Clinical Care: From Research to Routine Practice

2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Wearables have evolved from research-based instruments into commercially-available sensors that continuously capture real-world function and lived experiences. In multiple sclerosis (MS), accelerometry and ecological momentary assessments (EMAs) captured by wearables provide reliable indicators of health, activity, and sleep/wake patterns, holding strong …

Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 1

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …

Spinal Cord in MS: Key Clinical and Imaging Considerations

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Spinal cord disease is important in most people with MS , but is less emphasized in patient care, basic, clinical research, and therapeutic trials. Clinically relevant spinal cord disease in MS is crucial to recognize. How and when to image the spinal cord …

Making the Invisible Visible

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Invisible symptoms of multiple sclerosis (MS), including fatigue, cognitive/mood impairment, and sensory disturbances, are major contributors to functional decline and diminished quality of life (QoL), yet remain understudied, underrecognized, and undertreated in people with MS. In this session, we …